567 Shares in HCA Healthcare, Inc. $HCA Acquired by KPP Advisory Services LLC

KPP Advisory Services LLC acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 567 shares of the company’s stock, valued at approximately $217,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Price T Rowe Associates Inc. MD increased its holdings in HCA Healthcare by 83.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock worth $829,104,000 after purchasing an additional 1,091,416 shares in the last quarter. Goldman Sachs Group Inc. increased its holdings in HCA Healthcare by 49.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock worth $615,583,000 after purchasing an additional 587,036 shares in the last quarter. Nuveen LLC bought a new stake in HCA Healthcare during the 1st quarter worth approximately $569,217,000. Pacer Advisors Inc. grew its holdings in shares of HCA Healthcare by 6,237.9% in the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock valued at $466,815,000 after acquiring an additional 1,329,618 shares in the last quarter. Finally, Nordea Investment Management AB grew its holdings in shares of HCA Healthcare by 6.8% in the second quarter. Nordea Investment Management AB now owns 927,781 shares of the company’s stock valued at $350,404,000 after acquiring an additional 59,163 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Price Performance

NYSE:HCA opened at $440.07 on Friday. The company has a market cap of $102.97 billion, a P/E ratio of 18.50, a P/E/G ratio of 1.39 and a beta of 1.40. The stock’s fifty day moving average price is $413.82 and its two-hundred day moving average price is $380.88. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $447.09.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.20 by $0.64. The firm had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The business’s quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $5.50 earnings per share. On average, analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

Insider Activity

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 1.30% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on HCA shares. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $444.00 target price on shares of HCA Healthcare in a report on Tuesday, October 7th. JPMorgan Chase & Co. upped their target price on HCA Healthcare from $360.00 to $370.00 and gave the company a “neutral” rating in a report on Monday, August 4th. Truist Financial set a $460.00 target price on HCA Healthcare in a report on Tuesday, October 14th. Robert W. Baird increased their price objective on HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a report on Thursday, August 14th. Finally, Weiss Ratings reissued a “buy (b-)” rating on shares of HCA Healthcare in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average price target of $437.19.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.